Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

July 1, 2024

Conditions
Malignant Biliary Obstruction
Interventions
DEVICE

group 1

Insertion of fully covered self-expanding metallic stents with multi-holes (FCSEMS- MH) Biliary stent HANAROSTENT® CCC (M.I.Tech Co., Ltd, pyeongtaek, Korea) in a biliary tree through endoscopic retrograde cholangiopancreatography (ERCP) under general anesthesia by expertise in patients with malignant biliary obstruction

DEVICE

group 2

Insertion of partially covered self-expanding metallic stents HANAROSTENT® Biliary (NCN) in the biliary tree through ERCP under general anesthesia by Expertise in patients with malignant biliary obstruction.

DEVICE

group 3

Insertion of uncovered self-expanding metallic stents (Biliary stent HANAROSTENT® NNN) (M.I.Tech Co., Ltd. Pyeongtaek, Korea) in a biliary tree through ERCP under general anesthesia by Expertise in patients with malignant biliary obstruction.

Trial Locations (1)

44519

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV